Article
Integrative DNA methylation and gene expression analysis to assess the universality of the CpG island methylator phenotype.
Human genomics - 13 Oct 2015
Moarii Matahi, Reyal Fabien, Vert Jean-Philippe
Abstract excerpt
BACKGROUND: The CpG island methylator phenotype (CIMP) was first characterized in colorectal cancer but since has been extensively studied in several other tumor types such as breast, bladder, lung, and gastric. CIMP is of clinical importance as it has been reported to be associated with prognosis or response to treatment. However, the identification of a universal molecular basis to define CIMP across tumors has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
